Extracted from this filing and checked against the source text.
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
GeoVax Labs, Inc. issued an aggregate of up to 1,002,288 shares of the Company’s common stock of warrant to Holders of existing warrants for for their agreement to exercise for cash their Exercised Warrants to purchase an aggregate of 501,144 shares.
- Security
- warrant
- Shares
- an aggregate of up to 1,002,288 shares of the Company’s common stock
- Purchaser
- Holders of existing warrants
- Consideration
- for their agreement to exercise for cash their Exercised Warrants to purchase an aggregate of 501,144 shares
Exact text from the filing
with the September 2025 Warrants, the “Exercised Warrants”), pursuant to which the Holders agreed to exercise for cash their Exercised Warrants to purchase an aggregate of 501,144 shares of the Company’s common stock in consideration for the Company’s agreement to issue new warrants (the “New Warrants”) to purchase an aggregate of up to 1,002,288 shares of
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
GeoVax Labs, Inc. entered into Inducement Letters with holders of existing warrants valued at aggregate gross proceeds of approximately $595,000 (effective 2026-05-07).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- holders of existing warrants
- Value
- aggregate gross proceeds of approximately $595,000
- Effective
- 2026-05-07
Exact text from the filing
On May 7, 2026, GeoVax Labs Inc. (the “Company”), entered into common stock warrant exercise inducement offer letters (the “Inducement Letters”) with holders (the “Holders”) of existing warrants to purchase shares of the Company’s common stock
View on SEC.gov